Omalizumab in severe chronic urticaria: are slow and non-responders different? | Eur Ann Allergy Clin Immunol;53(6): 263-266, 2021 Nov. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Omalizumab in severe chronic urticaria: are slow and non-responders different?

Asero, R.

Affiliation

Asero R; Allergology Clinic, Clinica San Carlo, Paderno Dugnano, Milan, Italy.

Eur Ann Allergy Clin Immunol ; 53(6): 263-266, 2021 Nov.

Article in En | MEDLINE | ID: mdl-32914943

Subject(s)
Key words

Biomarkers; IgE; chronic urticaria; omalizumab; thyroid autoimmunity

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urticaria / Anti-Allergic Agents / Chronic Urticaria Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur Ann Allergy Clin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2021 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urticaria / Anti-Allergic Agents / Chronic Urticaria Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur Ann Allergy Clin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2021 Document type: Article Affiliation country: Country of publication: